OBJECTIVE The current literature does not provide unequivocal evidence on prognostic factors of patients' response to biofeedback for management of faecal incontinence. The aim of this study was to identify independent predictors of patient response to biofeedback. MATERIAL AND METHODS Baseline demographic characteristics, symptomatology and anorectal investigation reports of 137 patients who completed biofeedback therapy were analysed retrospectively. Short-term response (<3 months) to biofeedback was assessed using subjective criteria (improvement/ no improvement). P Values < 0.05 were considered to be statistically significant. RESULTS At univariate analysis, age, duration of symptoms, severity of faecal incontinence, mean...
Background: Anorectal functional disorder encompasses arrays of conditions including Obstructive Def...
BACKGROUND: Fecal incontinence affects up to 11% of Australian community-dwelling adults and 72% of ...
Biofeedback is a well-known and effective treatment for patients with fecal evacuation disorder (FED...
OBJECTIVE The current literature does not provide unequivocal evidence on prognostic factors of p...
BACKGROUND: The current literature does not provide unequivocal data on prognostic factors in conser...
Background Anorectal biofeedback therapy (BFT) is a safe and effective treatment in patients with co...
Abstract PURPOSE: Functional bowel outcome in patients with anorectal malformation often is poor. Fo...
ABSTRACT BACKGROUND: Biofeedback is an effective method of treatment for fecal incontinence but th...
The purpose of this study is to evaluate the predictive capability of anorectal physiologic tests fo...
AIMS: It is unclear which patients with fecal incontinence (FI) are likely to benefit from physiothe...
OBJECTIVE: to evaluate the effect of sphincter defect (SD) on biofeedback (BF) response in patients ...
Background: Instrumented anorectal biofeedback (BF) improves symptoms and quality of life in patient...
Constipation and faecal incontinence (FI) are common gastrointestinal disorders, affecting 8-18% of ...
Objective: To determine whether anorectal biofeedback therapy can improve the symptoms of fecal inco...
Purpose This study aims to establish the ability of patient-reported outcome measures (PROMs) and an...
Background: Anorectal functional disorder encompasses arrays of conditions including Obstructive Def...
BACKGROUND: Fecal incontinence affects up to 11% of Australian community-dwelling adults and 72% of ...
Biofeedback is a well-known and effective treatment for patients with fecal evacuation disorder (FED...
OBJECTIVE The current literature does not provide unequivocal evidence on prognostic factors of p...
BACKGROUND: The current literature does not provide unequivocal data on prognostic factors in conser...
Background Anorectal biofeedback therapy (BFT) is a safe and effective treatment in patients with co...
Abstract PURPOSE: Functional bowel outcome in patients with anorectal malformation often is poor. Fo...
ABSTRACT BACKGROUND: Biofeedback is an effective method of treatment for fecal incontinence but th...
The purpose of this study is to evaluate the predictive capability of anorectal physiologic tests fo...
AIMS: It is unclear which patients with fecal incontinence (FI) are likely to benefit from physiothe...
OBJECTIVE: to evaluate the effect of sphincter defect (SD) on biofeedback (BF) response in patients ...
Background: Instrumented anorectal biofeedback (BF) improves symptoms and quality of life in patient...
Constipation and faecal incontinence (FI) are common gastrointestinal disorders, affecting 8-18% of ...
Objective: To determine whether anorectal biofeedback therapy can improve the symptoms of fecal inco...
Purpose This study aims to establish the ability of patient-reported outcome measures (PROMs) and an...
Background: Anorectal functional disorder encompasses arrays of conditions including Obstructive Def...
BACKGROUND: Fecal incontinence affects up to 11% of Australian community-dwelling adults and 72% of ...
Biofeedback is a well-known and effective treatment for patients with fecal evacuation disorder (FED...